309 related articles for article (PubMed ID: 29311126)
1. Preclinical Models of Prostate Cancer: Patient-Derived Xenografts, Organoids, and Other Explant Models.
Risbridger GP; Toivanen R; Taylor RA
Cold Spring Harb Perspect Med; 2018 Aug; 8(8):. PubMed ID: 29311126
[TBL] [Abstract][Full Text] [Related]
2. A synopsis of prostate organoid methodologies, applications, and limitations.
Gleave AM; Ci X; Lin D; Wang Y
Prostate; 2020 May; 80(6):518-526. PubMed ID: 32084293
[TBL] [Abstract][Full Text] [Related]
3. Use of conditional reprogramming cell, patient derived xenograft and organoid for drug screening for individualized prostate cancer therapy: Current and future perspectives (Review).
Cao J; Chan WC; Chow MSS
Int J Oncol; 2022 May; 60(5):. PubMed ID: 35322860
[TBL] [Abstract][Full Text] [Related]
4. A PDX/Organoid Biobank of Advanced Prostate Cancers Captures Genomic and Phenotypic Heterogeneity for Disease Modeling and Therapeutic Screening.
Beshiri ML; Tice CM; Tran C; Nguyen HM; Sowalsky AG; Agarwal S; Jansson KH; Yang Q; McGowen KM; Yin J; Alilin AN; Karzai FH; Dahut WL; Corey E; Kelly K
Clin Cancer Res; 2018 Sep; 24(17):4332-4345. PubMed ID: 29748182
[No Abstract] [Full Text] [Related]
5. High-Throughput Imaging Assay for Drug Screening of 3D Prostate Cancer Organoids.
Choo N; Ramm S; Luu J; Winter JM; Selth LA; Dwyer AR; Frydenberg M; Grummet J; Sandhu S; Hickey TE; Tilley WD; Taylor RA; Risbridger GP; Lawrence MG; Simpson KJ
SLAS Discov; 2021 Oct; 26(9):1107-1124. PubMed ID: 34111999
[TBL] [Abstract][Full Text] [Related]
6. Novel patient-derived preclinical models of liver cancer.
Bresnahan E; Ramadori P; Heikenwalder M; Zender L; Lujambio A
J Hepatol; 2020 Feb; 72(2):239-249. PubMed ID: 31954489
[TBL] [Abstract][Full Text] [Related]
7. Application of Prostate Cancer Models for Preclinical Study: Advantages and Limitations of Cell Lines, Patient-Derived Xenografts, and Three-Dimensional Culture of Patient-Derived Cells.
Namekawa T; Ikeda K; Horie-Inoue K; Inoue S
Cells; 2019 Jan; 8(1):. PubMed ID: 30669516
[TBL] [Abstract][Full Text] [Related]
8. Generation of Prostate Cancer Patient-Derived Xenografts to Investigate Mechanisms of Novel Treatments and Treatment Resistance.
Lam HM; Nguyen HM; Corey E
Methods Mol Biol; 2018; 1786():1-27. PubMed ID: 29786784
[TBL] [Abstract][Full Text] [Related]
9. Viability Analysis and High-Content Live-Cell Imaging for Drug Testing in Prostate Cancer Xenograft-Derived Organoids.
Van Hemelryk A; Erkens-Schulze S; Lim L; de Ridder CMA; Stuurman DC; Jenster GW; van Royen ME; van Weerden WM
Cells; 2023 May; 12(10):. PubMed ID: 37408211
[TBL] [Abstract][Full Text] [Related]
10. Engineering Prostate Cancer from Induced Pluripotent Stem Cells-New Opportunities to Develop Preclinical Tools in Prostate and Prostate Cancer Studies.
Hepburn AC; Sims CHC; Buskin A; Heer R
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32019175
[TBL] [Abstract][Full Text] [Related]
11. Tumor Xenografts of Human Clear Cell Renal Cell Carcinoma But Not Corresponding Cell Lines Recapitulate Clinical Response to Sunitinib: Feasibility of Using Biopsy Samples.
Dong Y; Manley BJ; Becerra MF; Redzematovic A; Casuscelli J; Tennenbaum DM; Reznik E; Han S; Benfante N; Chen YB; Arcila ME; Aras O; Voss MH; Feldman DR; Motzer RJ; Fabbri N; Healey JH; Boland PJ; Chawla M; Durack JC; Lee CH; Coleman JA; Russo P; Hakimi AA; Cheng EH; Hsieh JJ
Eur Urol Focus; 2017 Dec; 3(6):590-598. PubMed ID: 28753786
[TBL] [Abstract][Full Text] [Related]
12. Bladder Cancer Patient-derived Organoids and Avatars for Personalized Cancer Discovery.
Kim YS; Hsieh AC; Lam HM
Eur Urol Focus; 2022 May; 8(3):657-659. PubMed ID: 35915037
[TBL] [Abstract][Full Text] [Related]
13. Organoid cultures derived from patients with advanced prostate cancer.
Gao D; Vela I; Sboner A; Iaquinta PJ; Karthaus WR; Gopalan A; Dowling C; Wanjala JN; Undvall EA; Arora VK; Wongvipat J; Kossai M; Ramazanoglu S; Barboza LP; Di W; Cao Z; Zhang QF; Sirota I; Ran L; MacDonald TY; Beltran H; Mosquera JM; Touijer KA; Scardino PT; Laudone VP; Curtis KR; Rathkopf DE; Morris MJ; Danila DC; Slovin SF; Solomon SB; Eastham JA; Chi P; Carver B; Rubin MA; Scher HI; Clevers H; Sawyers CL; Chen Y
Cell; 2014 Sep; 159(1):176-187. PubMed ID: 25201530
[TBL] [Abstract][Full Text] [Related]
14. A patient-derived explant (PDE) model of hormone-dependent cancer.
Centenera MM; Hickey TE; Jindal S; Ryan NK; Ravindranathan P; Mohammed H; Robinson JL; Schiewer MJ; Ma S; Kapur P; Sutherland PD; Hoffmann CE; Roehrborn CG; Gomella LG; Carroll JS; Birrell SN; Knudsen KE; Raj GV; Butler LM; Tilley WD
Mol Oncol; 2018 Sep; 12(9):1608-1622. PubMed ID: 30117261
[TBL] [Abstract][Full Text] [Related]
15. Interaction between Tumor Cell Surface Receptor RAGE and Proteinase 3 Mediates Prostate Cancer Metastasis to Bone.
Kolonin MG; Sergeeva A; Staquicini DI; Smith TL; Tarleton CA; Molldrem JJ; Sidman RL; Marchiò S; Pasqualini R; Arap W
Cancer Res; 2017 Jun; 77(12):3144-3150. PubMed ID: 28428279
[TBL] [Abstract][Full Text] [Related]
16. In vitro modeling of the prostate cancer microenvironment.
Ellem SJ; De-Juan-Pardo EM; Risbridger GP
Adv Drug Deliv Rev; 2014 Dec; 79-80():214-21. PubMed ID: 24816064
[TBL] [Abstract][Full Text] [Related]
17. Establishing a cryopreservation protocol for patient-derived xenografts of prostate cancer.
Porter LH; Lawrence MG; Wang H; Clark AK; Bakshi A; Obinata D; Goode D; Papargiris M; Mural ; Clouston D; Ryan A; Norden S; Corey E; Nelson PS; Isaacs JT; Grummet J; Kourambas J; Sandhu S; Murphy DG; Pook D; Frydenberg M; Taylor RA; Risbridger GP
Prostate; 2019 Aug; 79(11):1326-1337. PubMed ID: 31212368
[TBL] [Abstract][Full Text] [Related]
18. Generation of a C57BL/6 MYC-Driven Mouse Model and Cell Line of Prostate Cancer.
Ellis L; Ku S; Li Q; Azabdaftari G; Seliski J; Olson B; Netherby CS; Tang DG; Abrams SI; Goodrich DW; Pili R
Prostate; 2016 Sep; 76(13):1192-202. PubMed ID: 27225803
[TBL] [Abstract][Full Text] [Related]
19. Movember GAP1 PDX project: An international collection of serially transplantable prostate cancer patient-derived xenograft (PDX) models.
Navone NM; van Weerden WM; Vessella RL; Williams ED; Wang Y; Isaacs JT; Nguyen HM; Culig Z; van der Pluijm G; Rentsch CA; Marques RB; de Ridder CMA; Bubendorf L; Thalmann GN; Brennen WN; Santer FR; Moser PL; Shepherd P; Efstathiou E; Xue H; Lin D; Buijs J; Bosse T; Collins A; Maitland N; Buzza M; Kouspou M; Achtman A; Taylor RA; Risbridger G; Corey E
Prostate; 2018 Dec; 78(16):1262-1282. PubMed ID: 30073676
[TBL] [Abstract][Full Text] [Related]
20. Current experimental human tissue-derived models for prostate cancer research.
Kato M; Sasaki T; Inoue T
Int J Urol; 2021 Feb; 28(2):150-162. PubMed ID: 33247498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
